In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators
Rudolf Virchow was the first person to point out the important link between immune function and cancer. He did this by noticing that leukocytes were often found in tumors. Overexpression of arginase 1 (ARG1) and inducible nitric oxide synthase (iNOS) in myeloid-derived suppressor cells (MDSCs) and t...
Saved in:
Main Authors: | Magdi E. A. Zaki (Author), Sami A. Al-Hussain (Author), Aamal A. Al-Mutairi (Author), Abdul Samad (Author), Arabinda Ghosh (Author), Somdatta Chaudhari (Author), Pravin N. Khatale (Author), Prashant Ajmire (Author), Rahul D. Jawarkar (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures
by: Magdi E. A. Zaki, et al.
Published: (2022) -
Unveiling the Potential of BenzylethyleneAryl-Urea Scaffolds for the Design of New Onco Immunomodulating Agents
by: Raquel Gil-Edo, et al.
Published: (2023) -
Rational drug repurposing for alzheimer's treatment using in-silico ligand and structure-based approaches
by: Karishma Rathi, et al.
Published: (2024) -
MODERN ONCO DRUG FOR INTERNAL USE
by: O. L. Orlova, et al.
Published: (2018) -
The role of arginase in endothelial dysfunction
by: Rudolf Lucas
Published: (2015)